Immune targets for therapeutic development in depression: towards precision medicine

Over the past two decades, compelling evidence has emerged indicating that immune mechanisms can contribute to the pathogenesis of major depressive disorder (MDD) and that drugs with primary immune targets can improve depressive symptoms. Patients with MDD are heterogeneous with respect to symptoms,...

Descripción completa

Detalles Bibliográficos
Autores principales: Drevets, Wayne C., Wittenberg, Gayle M., Bullmore, Edward T., Manji, Husseini K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763135/
https://www.ncbi.nlm.nih.gov/pubmed/35039676
http://dx.doi.org/10.1038/s41573-021-00368-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763135/
https://www.ncbi.nlm.nih.gov/pubmed/35039676
http://dx.doi.org/10.1038/s41573-021-00368-1

Ejemplares similares